fbpx A new era for noninvasive cancer diagnosis | Page 6 | Science in the net
  1. Noninvasive cancer diagnosis
  2. Revisions
  3. A new era for noninvasive cancer diagnosis

A new era for noninvasive cancer diagnosis

Pubblicato il 11/02/2013Read time: 2 mins

Tumors release microvescicles containing protein and RNA fragments, called exosomes, into cerebral spinal fluid, blood, and urine. Exosome Diagnostics, a company based in New York, has developed a diagnostic test able to separate exosomes from bio-fluids and to extract their relevant genomic information. A team of researchers from the Massachusetts General Hospital reported that exosomes preserve the genetic information of their parental cells. By analyzing the genetic material contained in the exosomes, researchers aim to get accurate information about the nature, molecular composition and progression of the tumor.

Providing an early and accurate cancer diagnosis represents one of the major challenges in the battle against tumors. Nowadays a tissue biopsy is generally required in order for the doctors to formulate a correct diagnosis of the type of cancer and its progression status. However, for some tumor types, biopsies are invasive procedures with potential damaging side effects that, in extreme cases, could be life threatening.

A promising alternative to biopsies that hold the potential to revolutionize the cancer diagnosis field comes from studies on the communication between cancer cells and their microenvironment.

A multicenter clinical study using the Exosome diagnostic kit is now underway to validate this new strategy in glioblastoma (the most common form of brain cancer). Clinicians will periodically draw bio-fluids to monitor the state of the disease and will determine whether a patient is responding to therapy, something unthinkable until recently due to the extremely invasive nature of these kinds of biopsies.

Exosome diagnostic kits could potentially detect and monitor the progression of a wide variety of cancers, like prostate cancer. The most common noninvasive test for prostate cancer measures the blood level of PSA, a protein that is produced by the prostate gland. The higher a man’s PSA level, the more likely it is that he has prostate cancer. Nevertheless PSA test alone is not sufficient to accurately and undoubtedly detect prostate cancer. Exosome diagnostic kits specific for prostate cancer represent a substantial alternative to PSA test or they could be used in conjunction with current methods of diagnosis.Although more tests are required, exosomes hold promise to become an invaluable diagnostic tool to be exploited.

http://www.scientificamerican.com/article.cfm?id=rna-fragments-may-yield-rapid

Autori: 
di Francesca Zammarchi
Tumors diagnostic test
  • 4877 reads

prossimo articolo

The Log and the Speck: The True Causes of Wildfires and Floods

di Roberto Buizza
di Paolo Vineis
Pubblicato il 13/01/2025
The Parable of the Speck and the Log. Ottmar Ellinger the Younger

The wildfires in Los Angeles and other extreme events, as well as their media coverage, highlight how immediate causes often overshadow the real issue: climate change, which increases the intensity and frequency of catastrophic phenomena. Tackling this crisis requires urgent action to reduce greenhouse gas emissions using already available technologies and investments to strengthen territorial resilience. Only a combination of mitigation and adaptation can prevent irreversible damage, ensuring a sustainable future for the next generations.

In the image: The Parable of the Speck and the Log. Ottmar Ellinger the Younger

Environment

Even in the face of the vast Los Angeles wildfires—still ongoing—as in other recent circumstances, the media's attention is primarily focused on the most immediate and “proximal” causes: the malfunctioning of the power grid, insufficient water reserves, the unpreparedness of newly hired firefighters, and so on.